Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries

Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted cross-sectional online surveys to investigate COVID-19 vaccine acceptance across nine Low- and Middle-Income Countries (LMICs; N = 10,183), assuming vaccine effectiveness at 90% and 95%. The prevalence of vaccine acceptance increased from 76.4% (90% effectiveness) to 88.8% (95% effectiveness). Considering a 90% effective vaccine, Malaysia, Thailand, Bangladesh, and five African countries (Democratic Republic of Congo, Benin, Uganda, Malawi, and Mali) had lower acceptance odds compared to Brazil. Individuals who perceived taking the vaccine as important to protect themselves had the highest acceptance odds (aOR 2.49) at 95% effectiveness.Vaccine acceptance was also positively associated with COVID-19 knowledge, worry/fear regarding COVID-19, higher income, younger age, and testing negative for COVID-19. However, chronic disease and female gender reduced the odds for vaccine acceptance. The main reasons underpinning vaccine refusal were fear of side effects (41.2%) and lack of confidence in vaccine effectiveness (15.1%). Further research is needed to identify country-specific reasons for vaccine hesitancy in order to develop mitigation strategies that would ensure high and equitable vaccination coverage across LMICs.

[1]  C. Latkin,et al.  Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US , 2021, PloS one.

[2]  F. Alla,et al.  COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics , 2021, The Lancet Public Health.

[3]  E. Wouters,et al.  The pandemic of online research in times of COVID-19 , 2021, BMJ Open.

[4]  S. Luo,et al.  Intention to Receive the COVID-19 Vaccination in China: Application of the Diffusion of Innovations Theory and the Moderating Role of Openness to Experience , 2021, Vaccines.

[5]  J. Nachega,et al.  COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey , 2021, Vaccines.

[6]  Malik Sallam.  COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates , 2021, Vaccines.

[7]  P. Hyland,et al.  Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom , 2021, Nature Communications.

[8]  C. Demirdover.  COVID-19-vaccines , 2021, Reactions Weekly.

[9]  L. De Freitas,et al.  Combating the COVID-19 infodemic: a three-level approach for low and middle-income countries , 2021, BMJ Global Health.

[10]  A. Mahafzah,et al.  High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries , 2021, Vaccines.

[11]  L. Wong,et al.  Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. , 2020, PLoS neglected tropical diseases.

[12]  B. Bell,et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  H. Mercier,et al.  Sharp rise in vaccine hesitancy in a large and representative sample of the French population: reasons for vaccine hesitancy. , 2020 .

[14]  N. Nagelkerke,et al.  Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey , 2020, PloS one.

[15]  Lawrence O Gostin,et al.  A global survey of potential acceptance of a COVID-19 vaccine , 2020, Nature Medicine.

[16]  G. D. Salali,et al.  COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey , 2020, Psychological Medicine.

[17]  L. Kabamba Ngombe,et al.  Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo , 2020, Pragmatic and observational research.

[18]  Jamie L. Jensen,et al.  Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States , 2020, Vaccines.

[19]  E. Emanuel,et al.  Fairly Prioritizing Groups for Access to COVID-19 Vaccines. , 2020, JAMA.

[20]  M. Pennell,et al.  Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? , 2020, Vaccine.

[21]  I. Torjesen.  Covid-19: Pre-purchasing vaccine—sensible or selfish? , 2020, BMJ.

[22]  L. Wong,et al.  The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay , 2020, Human vaccines & immunotherapeutics.

[23]  H. Harapan,et al.  Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia , 2020, Frontiers in Public Health.

[24]  W. Brouwer,et al.  Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 , 2020, The European Journal of Health Economics.

[25]  David K. Jones,et al.  Neighborhood income and physical distancing during the COVID-19 pandemic in the U.S. , 2020, medRxiv.

[26]  P. Flowers,et al.  Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content , 2020, medRxiv.

[27]  A. Dror,et al.  Vaccine hesitancy: the next challenge in the fight against COVID-19 , 2020, European Journal of Epidemiology.

[28]  S. McFadden,et al.  Determinants of COVID-19 vaccine acceptance in the US , 2020, EClinicalMedicine.

[29]  T. Lancet.  COVID-19 in Brazil: “So what?” , 2020, The Lancet.

[30]  S. Mein.  COVID-19 and Health Disparities: the Reality of “the Great Equalizer” , 2020, Journal of General Internal Medicine.

[31]  F. Marson,et al.  COVID-19 in Brazil , 2020, Pulmonology.

[32]  M. Salathé,et al.  COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation. , 2020, Swiss medical weekly.

[33]  Lixia He,et al.  Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey , 2018, BMC Women's Health.

[34]  S. Klein,et al.  Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. , 2017, Annual review of cell and developmental biology.

[35]  R. Coker,et al.  Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review. , 2016, Journal of public health.

[36]  H. Larson,et al.  Strategies for addressing vaccine hesitancy - A systematic review. , 2015, Vaccine.

[37]  S. Ratzan,et al.  Addressing the vaccine confidence gap , 2011, The Lancet.

[38]  Jelke Bethlehem,et al.  Selection Bias in Web Surveys , 2010 .

[39]  Patrick Monahan,et al.  Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection , 2007, Annals of Internal Medicine.

[40]  R. Spitzer,et al.  The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener , 2003, Medical care.

[41]  Ibrahim S. Yansaneh.  Construction and use of sample weights , 2003 .